Procter & Gamble to Incur Up to $2.5 Billion in Charges for Gillette Write-Down and Market Restructuring

https://icaro.icaromediagroup.com/system/images/photos/15918405/original/open-uri20231205-56-1nspxs3?1701811007
ICARO Media Group
News
05/12/2023 20h52

Dec 5 (Reuters) - Procter & Gamble (PG.N) announced on Tuesday that it would be recording charges of up to $2.5 billion over the course of two fiscal years. The charges are related to the write-down of the value of its Gillette business and the restructuring of certain markets.

In the current quarter ending on December 31, P&G will take a non-cash impairment charge of $1.3 billion before tax on its Gillette business. The consumer goods giant, which acquired Gillette for $57 billion in 2005, derives about 8% of its total sales from the grooming business.

During a Morgan Stanley conference on Tuesday, P&G's Chief Financial Officer Andre Schulten stated that the company expected its Gillette business to experience growth in the range of 5%, consistent with the growth witnessed over the past three years.

Last year, P&G incurred an $8 billion charge on the Gillette unit due to currency fluctuations. In response to challenging macroeconomic conditions, the company anticipates charges of between $1 billion and $1.5 billion after tax associated with the restructuring of its operations in Argentina and Nigeria. P&G cited a stronger dollar as one of the contributing factors to these charges.

Schulten emphasized the difficulties faced by a U.S. dollar-denominated company in creating value within these markets. Consequently, P&G is intending to divest its fabric and home care business in Argentina and transform Nigeria into an import-only market.

The total charges, including the Gillette write-down and the market restructuring, are projected to be between $2 billion and $2.5 billion after tax. These charges will be recognized in fiscal years 2024 and 2025.

For the fiscal year 2023, net earnings attributable to Procter & Gamble were reported to be $14.7 billion.

It is important to note that the information provided is based solely on the details disclosed by Procter & Gamble in their announcement.

The views expressed in this article do not reflect the opinion of ICARO, or any of its affiliates.

Related